Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 6/17/2025

Treatment of Leucoma after Disciform Keratitis

Introduction to Treatment

  • The American Academy of Ophthalmology recommends using the minimum amount of corticosteroids necessary to control inflammation, with the goal of minimizing corneal scarring and optimizing visual recovery 1

Corticosteroid and Antiviral Therapy

  • The American Academy of Ophthalmology suggests maintaining antiviral therapy throughout the period of corticosteroid use to prevent viral reactivation, with a strength of evidence based on clinical guidelines 1
  • Prednisolone acetate 1% or phosphate 1% is recommended, 4 times a day, with dosage adjustments based on clinical response 1, 2
  • Corticosteroids should be avoided if Nocardia or fungal infection is suspected, due to the risk of worsening the infection 1, 2
  • For patients with herpes simplex virus (HSV) or varicella-zoster virus (VZV) infections, aciclovir topical 5 times a day or aciclovir oral 400mg 5 times a day is suggested, in combination with corticosteroids, to effectively manage disciform keratitis 1

Monitoring and Follow-up

  • Regular monitoring of intraocular pressure is necessary to prevent complications such as glaucoma, with a strength of evidence based on clinical guidelines 1
  • Patients should be informed about the risks of long-term corticosteroid therapy, including cataracts and glaucoma, to ensure informed decision-making 1
  • Patients should be evaluated for clinical response every 24-48 hours initially, with signs of improvement including reduction of stromal edema, decrease in keratic precipitates, improvement in visual acuity, and reduction of anterior chamber inflammation 1
  • If no improvement is seen within 48 hours, consideration should be given to increasing the frequency of corticosteroids, reevaluating the etiologic diagnosis, or performing corneal culture or biopsy if non-viral infection is suspected 1

Complications and Recurrence

  • Chronic use of topical immunotherapy increases the risk of infectious crystalline keratopathy, highlighting the need for careful management and monitoring 1, 2
  • The American Academy of Ophthalmology recommends a gradual reduction of corticosteroids based on clinical response, with consideration of prophylactic antiviral therapy in cases of recurrence, to minimize the risk of complications and promote optimal outcomes 1
  • Frequent visits during the acute phase and long-term monitoring are necessary to detect recurrences, and in cases of recurrence, consideration should be given to prophylactic antiviral therapy 2
  • The treatment of disciform keratitis requires careful regulation of corticosteroid dosage, optimal timing of application, and concurrent antiviral medication, as well as close monitoring, to achieve successful outcomes 2